SAN DIEGO, Oct. 29, 2001 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) today announced that Edward F. Calesa, chairman, president and CEO, will present at the CIBC World Markets Twelfth Annual Health Care Conference. The Conference will be held Monday, November 5, through Wednesday, November 7, 2001 at The Plaza Hotel in New York City.
Mr. Calesa's presentation is scheduled for Wednesday, November 7, 2001, from 1:30 - 2:00 p.m. eastern time and will include discussion of business operations and strategic plans for the Company.
During the three-day Conference, 120 public and 40 private health care companies (pharmaceuticals, services, biotechnology, informatics, devices and diagnostics) will present to an expected audience of 1,300 attendees.
Mr. Calesa's presentation at the CIBC World Markets Twelfth Annual Health Care Conference will be available to all interested parties through a live audio Webcast with slides on the Company's Website at www.womenfirst.com (Investor Relations, Management Interviews/Presentations area) on Wednesday, November 7, 2001 at 1:30 p.m. eastern time. RealPlayer or Windows Media Player are the required software plug-ins. Links to easily download free versions of both plug-ins will be available within the womenfirst.com Investor Relations, Management Interviews/Presentations area. After the Conference on Thursday, November 8, Mr. Calesa's CIBC presentation Webcast will be archived for on-demand viewing on womenfirst.com for three months. The archived version will also include a dial-in telephone number listed with the presentation for viewers without computer speakers.
About Women First HealthCare, Inc.
Women First HealthCare, Inc. (Nasdaq:WFHC) is a San Diego-based specialty pharmaceutical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceutical products -- the Company's primary emphasis -- and lifestyle products to meet their needs. Women First HealthCare is specifically targeted to women age 40+ and their clinicians. An internationally recognized Health Advisory Board of experts in women's health guides Women First HealthCare in the development of information and products for women and clinicians as women transition from perimenopause through postmenopause. The Company operates in three segments: Pharmaceuticals, Consumer Business, and Corporate Marketing. Product focus currently includes estrogen replenishment, headache management, antibacterial/urinary tract infection management, dietary supplementation, and self-care/lifestyle. Further information about Women First HealthCare can be found online at www.womenfirst.com, About Us and Investor Relations. Information about the Company's As We Change(r) national mail order catalog and Internet retailer can also be found online at www.aswechange.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to various risks, and Women First HealthCare, Inc. cautions you that any forward-looking information is not a guarantee of future performance. Women First HealthCare, Inc. disclaims any intent or obligation to update these forward-looking statements. Actual results could differ materially due to a number of factors, including (i) we have incurred significant losses since we were founded in November 1996, and if midlife women do not use, and their clinicians do not recommend, the products we offer, we will continue to experience significant losses; (ii) there is a limited market awareness of our Company and the products and services we offer; (iii) we may not be able to identify appropriate licensing, co-promotion or acquisition candidates in the future or to take advantage of the opportunities we identify; (iv) we and our products face significant competition; (v) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (vi) we are dependent on single sources of supply for all of the products we offer; and (vii) additional factors set forth in the Company's Securities and Exchange Commission filings including its Annual Report on Form 10-K for the period ended December 31, 2000 and its Form 10-Q for the period ended June 30, 2001.